Daytime Drowsiness a Sign of Alzheimer's?

Title: Daytime Drowsiness a Sign of Alzheimer's?Category: Health NewsCreated: 9/11/2018 12:00:00 AMLast Editorial Review: 9/12/2018 12:00:00 AM
Source: MedicineNet Alzheimer - Category: Geriatrics Source Type: news

Related Links:

Conditions:   Mild Cognitive Impairment;   Dementia;   Intermittent Claudication Intervention:   Behavioral: Leg ischemia Sponsors:   Aristotle University Of Thessaloniki;   Greek Alzheimer's Association and Related Disorders Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Condition:   Alzheimer's Disease Intervention:   Drug: F-18 PMPBB3 Sponsor:   Chang Gung Memorial Hospital Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Publication date: Available online 18 November 2019Source: NeuroImage: ClinicalAuthor(s): Patrizia Vannini, Federico d'Oleire Uquillas, Heidi I.L. Jacobs, Jorge Sepulcre, Jennifer Gatchel, Rebecca E. Amariglio, Bernard Hanseeuw, Kathryn V. Papp, Trey Hedden, Dorene M. Rentz, Alvaro Pascual-Leone, Keith A. Johnson, Reisa. A. SperlingAbstractThe ability to accurately judge memory efficiency (meta-memory monitoring) for newly learned (episodic) information, is decreased in older adults and even worse in Alzheimer's disease (AD), whereas no differences have been found for semantic meta-memory. The pathological substrates of th...
Source: NeuroImage: Clinical - Category: Radiology Source Type: research
Publication date: Available online 18 November 2019Source: The Lancet NeurologyAuthor(s): John F Cryan, Kenneth J O'Riordan, Kiran Sandhu, Veronica Peterson, Timothy G DinanSummaryResearch into the role of the gut microbiome in modulating brain function has rapidly increased over the past 10 years, albeit chiefly in animal models. Increasing clinical and preclinical evidence implicates the microbiome as a possible key susceptibility factor for neurological disorders, including Alzheimer's disease, autism spectrum disorder, multiple sclerosis, Parkinson's disease, and stroke. Cross-sectional clinical studies are bolstering ...
Source: The Lancet Neurology - Category: Neurology Source Type: research
Publication date: November 2019Source: Alzheimer's &Dementia, Volume 15, Issue 11Author(s):
Source: Alzheimer's and Dementia: The Journal of the Alzheimer's Association - Category: Geriatrics Source Type: research
Publication date: November 2019Source: Alzheimer's &Dementia, Volume 15, Issue 11Author(s):
Source: Alzheimer's and Dementia: The Journal of the Alzheimer's Association - Category: Geriatrics Source Type: research
Publication date: November 2019Source: Alzheimer's &Dementia, Volume 15, Issue 11Author(s): Stacie Weninger, Bjorn Sperling, Lisa J. Bain, Maria C. Carillo
Source: Alzheimer's and Dementia: The Journal of the Alzheimer's Association - Category: Geriatrics Source Type: research
Publication date: November 2019Source: Alzheimer's &Dementia, Volume 15, Issue 11Author(s):
Source: Alzheimer's and Dementia: The Journal of the Alzheimer's Association - Category: Geriatrics Source Type: research
DiscussionThe Cognigram was well liked in waiting rooms of primary care settings. Assistance from a trained adult and clinic endorsement were keys to success. How the Cognigram performs in a geographically compact, population-dense global setting, such as Brooklyn with high vascular disease risk and a plethora of health disparities, is being tested.
Source: Alzheimer's and Dementia: The Journal of the Alzheimer's Association - Category: Geriatrics Source Type: research
Publication date: November 2019Source: Alzheimer's &Dementia, Volume 15, Issue 11Author(s):
Source: Alzheimer's and Dementia: The Journal of the Alzheimer's Association - Category: Geriatrics Source Type: research
More News: Alzheimer's | Geriatrics